We are live on
!
Find out more
Celldex Therapeutics
CLDX
CLDX
138 hedge funds and large institutions have $281M invested in Celldex Therapeutics in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 45
2% less funds holding
Funds holding: 141 → 138 (-3)
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
17% less call options, than puts
Call options by funds: $2.24M | Put options by funds: $2.7M
19% less capital invested
Capital invested by funds: $348M → $281M (-$66.5M)
Holders
138
Holders Change
-3
Holders Change %
-2.13%
% of All Funds
3.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
45
Reduced
45
Closed
18
Calls
$2.24M
Puts
$2.7M
Net Calls
-$464K
Net Calls Change
-$571K
Top Buyers
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$4.38M |
| 2 |
D.E. Shaw & Co
New York
|
+$4.36M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.88M |
| 4 |
Renaissance Technologies
New York
|
+$2M |
| 5 |
Millennium Management
New York
|
+$1.94M |
